|
SMG5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.954200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.119800E-01 |
| Normal-vs-Stage2 |
3.565200E-01 |
| Normal-vs-Stage3 |
2.221700E-02 |
| Normal-vs-Stage4 |
9.102400E-03 |
| Stage1-vs-Stage2 |
9.094800E-01 |
| Stage1-vs-Stage3 |
1.789450E-01 |
| Stage1-vs-Stage4 |
4.001900E-02 |
| Stage2-vs-Stage3 |
4.026000E-01 |
| Stage2-vs-Stage4 |
1.387800E-01 |
| Stage3-vs-Stage4 |
3.052200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.084100E-02 |
| Normal-vs-AfricanAmerican |
2.029600E-02 |
| Normal-vs-Asian |
8.154400E-02 |
| Caucasian-vs-AfricanAmerican |
7.496200E-02 |
| Caucasian-vs-Asian |
5.205000E-01 |
| AfricanAmerican-vs-Asian |
3.048200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.379400E-01 |
| Normal-vs-Female |
2.843900E-02 |
| Male-vs-Female |
4.489600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.299800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.716300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.050300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.545000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.659600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.835800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.708400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.230600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.827800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.907600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.299800E-01 |
| Classical-VS-Follicular |
1.74669999997157E-06 |
| Classical-VS-Other |
1.140410E-01 |
| Classical-VS-Normal |
1.658370E-03 |
| Tall-VS-Follicular |
1.083240E-03 |
| Tall-VS-Other |
5.035600E-02 |
| Tall-VS-Normal |
5.663200E-03 |
| Follicular-VS-Other |
9.944600E-01 |
| Follicular-VS-Normal |
1.318230E-01 |
| Other-VS-Normal |
4.221600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.080400E-01 |
| Normal-vs-N1 |
7.097600E-01 |
| N0-vs-N1 |
6.124200E-01 |
|
|
